Physician profile
Alejandro Presilla
NPI 1902835747
$2,151.51
in general payments reported to CMS, 2019-2025
14 companies · $462 in 2025
The $462 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2020: $239 · 2021: $448 · 2022: $160 · 2023: $170 · 2024: $150 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $781.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $570.05 | 2019-2020 | |
| Stryker Corporation | $322.61 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boehringer Ingelheim Pharmaceuticals, INC. | $269.45 | 2019-2024 | Jardiance |
| Medtronic, INC. | $218.09 | 2021-2022 | |
| Amgen INC. | $180.80 | 2019-2021 | |
| Biotronik INC. | $138.99 | 2025 | Acticor 7 Vr-T Dx |
| Dexcom, INC. | $131.68 | 2023 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $118.02 | 2021-2023 | |
| Abiomed | $114.77 | 2021 | |
| Lantheus Medical Imaging, INC. | $27.80 | 2024 | |
| Novo Nordisk INC | $16.38 | 2021 | |
| Bardy Diagnostics, INC. | $15.00 | 2020 | |
| Arbor Pharmaceuticals, INC. | $14.85 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $13.02 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Presilla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.